Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases, Rheumatology Medicine, vol.93, issue.1, pp.1-10 ,
Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group, Haematologica, vol.97, issue.4, pp.529-562, 2012. ,
Infliximab chimeric antitumor necrosis factor-?? monoclonal antibody as potential treatment for myelodysplastic syndromes, Leukemia & Lymphoma, vol.19, issue.4, pp.509-525, 2005. ,
DOI : 10.1111/j.1365-2257.1997.tb00007.x
Trisomy 8 Involved in Myelodysplastic Syndromes as a Risk Factor for Intestinal Ulcers and Thrombosis ??? Beh??et's Syndrome, Leukemia & Lymphoma, vol.55, issue.1-2, pp.115-136, 2001. ,
DOI : 10.1016/S0145-2126(98)00097-6
A case of arthritis and vasculitis associated with the refractory anemia with excess of blasts syndrome resistant to glucocorticoid treatment that responded favorably to TNF-alpha blockade, Clinical and experimental rheumatology, vol.24, issue.2, pp.31-35, 2006. ,
Refractoriness of Intestinal Beh??et's Disease with Myelodysplastic Syndrome Involving Trisomy 8 to Medical Therapies - Our Case Experience and Review of the Literature, Digestion, vol.88, issue.4, pp.217-238, 2013. ,
DOI : 10.1159/000355341
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia, Leukemia Research, vol.43, pp.13-20, 2016. ,
DOI : 10.1016/j.leukres.2016.02.005
URL : https://hal.archives-ouvertes.fr/hal-01278608
A Proportional Hazards Model for the Subdistribution of a Competing Risk, Journal of the American Statistical Association, vol.69, issue.446, pp.496-509, 1999. ,
DOI : 10.1093/biomet/69.1.239
Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells. Leukemia research Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study, Arthritis Care Res, vol.35, issue.128, pp.35-6631188 ,
Autoimmune Phenomena in Patients with Myelodysplastic Syndromes, Leukemia & Lymphoma, vol.24, issue.5-6, pp.5-6483, 1997. ,
DOI : 10.1016/S0190-9622(09)80090-X
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study Biologics in vasculitides: Where do we stand, where do we go from now, Leukemia. Presse Med, vol.1644, issue.166 2, pp.162-166, 2002. ,
Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature, Autoimmunity Reviews, vol.16, issue.4, pp.377-84, 2017. ,
DOI : 10.1016/j.autrev.2017.02.008
Autoimmune diseases and myelodysplastic syndromes, American Journal of Hematology, vol.99, issue.5, pp.280-283, 2016. ,
DOI : 10.3324/haematol.2012.083345
Epidemiology and risk factors for infections in myelodysplastic syndromes. Transplant infectious disease : an official journal of the Transplantation Society, pp.652-659, 2013. ,